Pre-clinical evaluation of a divalent liposomal vaccine to control invasive candidiasis

Abstract Candida albicans causes systemic infections with 20–50% mortality in critically ill and immunocompromised patients, despite antifungal treatment. Current therapies face limitations, including toxicity and resistance, underscoring the need for prophylactic vaccines. This study presents a nov...

Full description

Saved in:
Bibliographic Details
Main Authors: Augusto Costa-Barbosa, Maria Inês Pacheco, Andreia C. Gomes, Tony Collins, Manuel Vilanova, Célia Pais, Alexandra Correia, Paula Sampaio
Format: Article
Language:English
Published: Nature Portfolio 2025-06-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-025-01183-0
Tags: Add Tag
No Tags, Be the first to tag this record!